B
Bioscience Animal Health PCL
SET:BIS
Bioscience Animal Health PCL
SET:BIS
Price:
2.06
THB
Market Closed
Market Cap:
฿646.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
Chicony Electronics Co Ltd
TWSE:2385
|
TW |
|
H
|
Huitong Construction Group Co Ltd
SSE:603176
|
CN |
|
S
|
Streit Mecanique SA
PAR:MLSTR
|
FR |
|
Lingerie Fighting Championships Inc
OTC:BOTY
|
US |
|
Qingdao Eastsoft Communication Technology Co Ltd
SZSE:300183
|
CN |
|
E
|
Eimco Elecon India Ltd
NSE:EIMCOELECO
|
IN |
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
VN |
|
Burford Capital Ltd
NYSE:BUR
|
GG |
|
L
|
Luenmei Quantum Co Ltd
SSE:600167
|
CN |
|
EML Payments Ltd
ASX:EML
|
AU |
|
C
|
Clio Cosmetics Co Ltd
KOSDAQ:237880
|
KR |
|
Seabridge Gold Inc
TSX:SEA
|
CA |
|
Jiangsu Zhangjiagang Rural Commercial Bank Co Ltd
SZSE:002839
|
CN |
|
Dolby Laboratories Inc
NYSE:DLB
|
US |
|
American Homes 4 Rent
NYSE:AMH
|
US |
|
New Wave Group AB
STO:NEWA B
|
SE |
Cash Flow Statement
Cash Flow Statement
Bioscience Animal Health PCL
Bioscience Animal Health PCL
Currency: THB
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
78
|
50
|
53
|
60
|
66
|
70
|
72
|
78
|
79
|
|
| Depreciation & Amortization |
24
|
16
|
16
|
17
|
17
|
18
|
19
|
20
|
21
|
|
| Other Non-Cash Items |
11
|
23
|
20
|
26
|
26
|
29
|
35
|
33
|
36
|
|
| Cash Taxes Paid |
23
|
12
|
12
|
12
|
16
|
17
|
22
|
23
|
22
|
|
| Cash Interest Paid |
7
|
2
|
2
|
2
|
2
|
2
|
1
|
3
|
2
|
|
| Change in Working Capital |
(208)
|
(130)
|
(112)
|
(210)
|
(77)
|
(88)
|
(21)
|
25
|
107
|
|
| Cash from Operating Activities |
(95)
N/A
|
(41)
+57%
|
(23)
+45%
|
(107)
-376%
|
33
N/A
|
29
-11%
|
104
+259%
|
155
+49%
|
243
+57%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(21)
|
(11)
|
(8)
|
(12)
|
(13)
|
(8)
|
(7)
|
(4)
|
(1)
|
|
| Other Items |
(56)
|
62
|
70
|
152
|
41
|
42
|
6
|
(81)
|
(175)
|
|
| Cash from Investing Activities |
(77)
N/A
|
50
N/A
|
62
+23%
|
140
+127%
|
28
-80%
|
33
+21%
|
(1)
N/A
|
(85)
-7 018%
|
(176)
-108%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
564
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(281)
|
(58)
|
(3)
|
(3)
|
(15)
|
(4)
|
38
|
(7)
|
(24)
|
|
| Cash Paid for Dividends |
(129)
|
(32)
|
(32)
|
0
|
(35)
|
(38)
|
(38)
|
0
|
(44)
|
|
| Other |
(23)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
0
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
131
N/A
|
(90)
N/A
|
(36)
+60%
|
(36)
0%
|
(51)
-40%
|
(43)
+14%
|
1
N/A
|
(46)
N/A
|
(68)
-48%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
0
|
0
|
0
|
(2)
|
(1)
|
(1)
|
0
|
|
| Net Change in Cash |
(41)
N/A
|
(81)
-99%
|
3
N/A
|
(4)
N/A
|
10
N/A
|
17
+74%
|
103
+519%
|
23
-77%
|
(0)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(116)
N/A
|
(52)
+55%
|
(31)
+41%
|
(119)
-284%
|
19
N/A
|
21
+10%
|
97
+360%
|
151
+55%
|
242
+61%
|
|
Switch to:
Switch to:
See Also
Discover More
